466 related articles for article (PubMed ID: 15630497)
1. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
[TBL] [Abstract][Full Text] [Related]
2. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
[TBL] [Abstract][Full Text] [Related]
3. The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian Population.
Akhter MS; Biswas A; Abdullah SM; Behari M; Saxena R
Clin Appl Thromb Hemost; 2017 Nov; 23(8):1071-1076. PubMed ID: 28460568
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
Wiklund PG; Nilsson L; Ardnor SN; Eriksson P; Johansson L; Stegmayr B; Hamsten A; Holmberg D; Asplund K
Stroke; 2005 Aug; 36(8):1661-5. PubMed ID: 16020771
[TBL] [Abstract][Full Text] [Related]
5. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
6. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
7. 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke.
Chen CH; Eng HL; Chang CJ; Tsai TT; Lai ML; Chen HY; Liu CJ; Lin TM
J Lab Clin Med; 2003 Aug; 142(2):100-5. PubMed ID: 12960956
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.
Ding J; Nicklas BJ; Fallin MD; de Rekeneire N; Kritchevsky SB; Pahor M; Rodondi N; Li R; Zmuda JM; Harris TB
Am Heart J; 2006 Dec; 152(6):1109-15. PubMed ID: 17161063
[TBL] [Abstract][Full Text] [Related]
9. A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease.
Adamski MG; Turaj W; Slowik A; Wloch-Kopec D; Wolkow P; Szczudlik A
Acta Neurol Scand; 2009 Aug; 120(2):94-100. PubMed ID: 19154538
[TBL] [Abstract][Full Text] [Related]
10. An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke.
Boncoraglio GB; Bodini A; Brambilla C; Carriero MR; Ciusani E; Parati EA
Cerebrovasc Dis; 2006; 22(2-3):191-5. PubMed ID: 16735791
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic gene polymorphism and ischemic stroke.
Jood K; Ladenvall P; Tjärnlund-Wolf A; Ladenvall C; Andersson M; Nilsson S; Blomstrand C; Jern C
Stroke; 2005 Oct; 36(10):2077-81. PubMed ID: 16179568
[TBL] [Abstract][Full Text] [Related]
12. Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance.
Sartori MT; Vettor R; De Pergola G; De Mitrio V; Saggiorato G; Della Mea P; Patrassi GM; Lombardi AM; Fabris R; Girolami A
Thromb Haemost; 2001 Nov; 86(5):1161-9. PubMed ID: 11816701
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
[TBL] [Abstract][Full Text] [Related]
14. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly.
Hoekstra T; Geleijnse JM; Kluft C; Giltay EJ; Kok FJ; Schouten EG
Stroke; 2003 Dec; 34(12):2822-8. PubMed ID: 14605330
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R
Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
[TBL] [Abstract][Full Text] [Related]
16. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
[TBL] [Abstract][Full Text] [Related]
17. GLU298ASP and 4G/5G Polymorphisms and the Risk of Ischemic Stroke in Young Individuals.
Esparza-García JC; Santiago-Germán D; Guadalupe Valades-Mejía M; Hernández-Juárez J; Aguilar-Sosa E; Leaños-Miranda A; Alvarado-Moreno A; Majluf-Cruz A; Isordia-Salas I
Can J Neurol Sci; 2015 Sep; 42(5):310-6. PubMed ID: 26036781
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease.
Catto AJ; Carter AM; Stickland M; Bamford JM; Davies JA; Grant PJ
Thromb Haemost; 1997 Apr; 77(4):730-4. PubMed ID: 9134651
[TBL] [Abstract][Full Text] [Related]
19. Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai children with arterial ischemic stroke.
Natesirinilkul R; Sasanakul W; Chuansumrit A; Kadegasem P; Visudtibhan A; Wongwerawattanakoon P; Sirachainan N
J Stroke Cerebrovasc Dis; 2014; 23(10):2566-2572. PubMed ID: 25284719
[TBL] [Abstract][Full Text] [Related]
20. 4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.
Burzotta F; Iacoviello L; Di Castelnuovo A; Zamparelli R; D'Orazio A; Amore C; Schiavello R; Donati MB; Maseri A; Possati G; Andreotti F
J Thromb Thrombolysis; 2003 Dec; 16(3):149-54. PubMed ID: 15087600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]